Scar Treatments

A scar is often described as a mark left after an injury.

I think that description is too superficial.

A scar is the result of a biological decision the body had to make when normal tissue architecture could no longer be restored perfectly. The priority was to close the wound and regain strength. Collagen was produced, reorganised and remodelled to accomplish that job.

The resulting tissue may be flat and pale. It may become wide. It may sink below the surrounding surface. It may thicken and remain red or itchy. In a keloid, scar tissue can continue growing beyond the boundaries of the original injury.

All of these are called scars, but they are not one condition.

This is why I do not begin scar treatment with a laser, a needle or a cream. I begin by asking: what did this scar do differently during healing, and which part of that behaviour is still modifiable now?

A scar is not a stain that can simply be removed from the skin

This distinction matters because many patients have spent years using products that promise to “erase” a scar.

A mature scar is not merely a colour sitting on top of normal skin. Its collagen architecture, thickness, elasticity and relationship with the tissues beneath it may all be different.

If the scar is depressed, the surface may be physically tethered downward or there may be inadequate tissue support beneath it. If it is raised, excess fibrotic tissue has developed. If it is wide, tension and wound behaviour may have influenced the way the original edges healed. If the main difference is colour, the structural scar and the pigment may actually be two separate treatment problems.

That is why the statement “scar cream did not work” does not necessarily mean the scar is untreatable. It may simply mean a surface treatment was being asked to change deeper architecture.

Scars do not all fail in the same direction.

The treatment has to address the way this particular scar differs from normal tissue.

The first distinction is whether the scar is depressed, raised or structurally misplaced

An atrophic scar sits below the surrounding skin. Acne and chickenpox are familiar causes, but even within acne scarring there are several different architectures.

A hypertrophic scar moves in the opposite direction. It becomes thicker and raised but generally remains within the original wound boundaries. It may also stay red, firm, painful or itchy for a period of time.

A keloid behaves differently again. Scar tissue grows beyond the original injury, and the tendency can recur even after apparently successful treatment.

Then there are scars whose main problem is neither excessive nor deficient collagen. A surgical scar may be unusually wide, lie across an unfavourable direction, become contracted, pull on another structure or heal with a step-off between the wound edges.

These categories immediately change the treatment logic. A treatment designed to flatten excess scar tissue makes no sense for a depressed scar. A procedure intended to stimulate more collagen can be exactly the wrong biological message for a keloid.

Acne scars require more classification than the word “atrophic” provides

An acne-scar field is rarely uniform.

Some depressions are broad and shallow. Some have sharper edges. Some extend narrowly and deeply into the skin. Others are attached to deeper tissue by fibrous bands that pull the surface downward.

This is one reason patients can undergo repeated resurfacing or microneedling and still have specific scars that barely change.

If a scar is mechanically tethered, stimulating collagen in the overlying dermis does not necessarily release the structure holding it down. In selected cases, subcision can be used to release those fibrous attachments before or alongside remodelling treatment.

Other scars may respond better to fractional resurfacing, RF microneedling or another collagen-remodelling strategy. Very focal scar types may require different targeted methods again. Where a true volume deficit contributes to the depression, structural support can occasionally form part of a broader plan.

This is why I do not think there is one “best acne-scar treatment”.

The better question is which scar within the field needs which mechanism.

Scar treatment often works better when we stop making one device responsible for the whole face

Combination treatment is common in scar management, but I want to distinguish a rational combination from treatment stacking.

If one scar is tethered, release has a specific mechanical role. If the surrounding tissue then needs remodelling, microneedling RF or fractional laser may have another role. If persistent redness is the remaining problem after the contour improves, the vascular component can be considered separately.

That is a coherent combination because every intervention has a different job.

What I try to avoid is selecting three devices simply because the scar has not disappeared after the first one.

Changing treatments without changing the diagnosis often creates more recovery rather than more precision.

Raised scars are a problem of excessive healing, not insufficient treatment

Hypertrophic scars and keloids need almost the opposite mindset from atrophic scars.

The tissue is already producing an excessive fibrotic response. The objective is therefore not simply to stimulate more healing but to control the activity of the scar.

Silicone-based treatment, intralesional therapies and selected laser or other adjunctive approaches can be useful depending on the scar’s stage, thickness, symptoms, location and previous behaviour. Contemporary scar management generally relies on combinations and repeated reassessment because no single treatment reliably solves every hypertrophic scar or keloid. :contentReference[oaicite:4]{index=4}

This is particularly important in keloids.

A keloid has a genuine recurrence tendency. Cutting it out does not remove that biology. In fact, surgery creates another injury — exactly the event that triggered abnormal scar growth in the first place.

That does not mean surgery can never be part of keloid management. It means excision should not be presented as though removing the visible tissue has removed the tendency to produce it.

A keloid should be managed, not promised a cure

I think expectation language is especially important here.

A patient may have undergone a previous treatment and watched the keloid return. They understandably ask whether another attempt has any point.

Sometimes it does.

Different combinations can flatten the scar, reduce symptoms and improve control. But recurrence risk remains part of the condition. I would rather explain that honestly than describe a period of improvement as permanent cure.

The goal may be a flatter, quieter and less symptomatic scar with long-term monitoring rather than the complete biological disappearance of keloid behaviour.

That is still meaningful treatment. It simply has to be judged against the correct endpoint.

Timing is part of the diagnosis

A fresh scar and a mature scar are different tissues.

Scars change substantially during maturation. Early redness, firmness and visibility can soften naturally as collagen reorganises. This is why a scar that looks worrying several weeks after surgery should not automatically be judged as the final result.

But I also do not use a simplistic rule that every scar must be ignored for a fixed number of months.

Some early scar behaviours deserve active management. A scar that is beginning to thicken, remains excessively inflamed, becomes symptomatic or shows signs of problematic contraction may benefit from intervention before complete maturation. Silicone, tension management, sun protection and selected therapies can form part of early scar care depending on the situation.

Other interventions are better delayed until enough maturation has occurred for us to see which problems will persist.

“Wait” and “treat early” can both be correct scar advice.

The important question is what the scar is doing during that time.

Colour and contour should be assessed separately

A scar may have an acceptable shape and still be very visible because it is red.

Another may be flat but darker than the surrounding skin because of post-inflammatory pigmentation.

Another may have excellent colour but remain depressed or raised enough to cast a shadow.

These features need different treatment logic.

A patient who says “my scar is still there” may actually be most bothered by colour rather than structure. If I improve the contour but ignore the colour, the patient may feel that very little has changed. The opposite is also true: improving redness does not flatten a hypertrophic scar.

I therefore try to identify which characteristic is actually making the scar visible before selecting treatment.

Skin tone changes how aggressively I am willing to create inflammation

Procedural scar treatments deliberately create biological change, and many do so through controlled injury or heat.

That means pigmentation matters.

Skin that has a strong tendency toward post-inflammatory hyperpigmentation may respond to the same procedure differently from skin with a lower pigment response. Device type, energy, treatment depth, sun exposure and aftercare all influence that balance.

This does not mean darker skin cannot be treated. It means “safe for every skin type” is not a sufficient treatment plan.

I want the scar to become less visible without replacing a texture problem with a pigment problem.

Surgical scar revision creates another scar — deliberately

The phrase scar revision can sound as though surgery removes a scar and returns normal unscarred skin.

That is not what happens.

Surgical revision removes or rearranges the existing scar and creates a new wound under more controlled conditions. The objective may be a finer line, better orientation, improved contour, reduced tension or release of a contracture.

This can be very useful when the problem is fundamentally architectural. A markedly widened scar, an unfavourably positioned scar or a scar that distorts another structure may not be correctable through surface treatment alone.

But the patient must still have the biological ability to heal the new wound favourably.

The operation gives the scar another opportunity to heal better. It does not grant immunity from scarring.

Tension can matter as much as the technique used to close the wound

Scars do not heal in isolation from mechanics.

A wound under significant tension can widen or remain active even when the initial suturing was technically good. Body location, movement and the direction of the scar relative to natural skin tension all influence its behaviour.

This is especially relevant when considering revision.

If I simply remove a wide scar without addressing why it widened, I may reproduce the same problem.

The revision plan therefore needs to consider closure mechanics, tissue availability, orientation and postoperative tension management rather than focusing only on making the old scar disappear on the day of surgery.

Scars change slowly, and treatment has to respect that timeline

Collagen remodelling is biological work.

Whether we are stimulating an atrophic scar, calming a hypertrophic scar or creating a new surgical revision, the final behaviour cannot be known immediately.

This makes scar treatment particularly vulnerable to overtreatment. A patient sees the scar after one month, wants faster improvement and adds another procedure before the previous tissue response has matured.

I prefer to leave enough time between meaningful interventions to understand what the tissue has actually done.

Sometimes the result continues improving without another procedure. Sometimes a residual component becomes clear and gives us a better target. Sometimes the scar has reached a plateau and another mechanism becomes reasonable.

The interval is not wasted time. It is diagnostic information.

Complete scar removal is not a realistic endpoint

This is the expectation I want clear from the beginning.

A scar represents permanently altered tissue. Treatment may make it flatter, narrower, smoother, softer, less pigmented, less red or better integrated with the surrounding skin.

A very successful scar can become difficult to notice in ordinary life.

That is different from saying the skin was returned to a state in which the injury never happened.

I treat scars for improvement, not erasure.

A realistic endpoint gives us room to pursue a meaningful result without chasing normal skin through endless procedures.

When scar treatment makes sense to me

I want to know that there is a defined feature we can realistically improve.

For an atrophic scar, that may be tethering, depth or surrounding dermal quality. For a raised scar, it may be thickness, activity, redness or symptoms. For a surgical scar, the main issue may be width, orientation or contracture. Sometimes colour is the dominant concern.

There are also scars I would initially leave alone.

A young scar that is evolving normally may need protection, appropriate scar care and time more than another procedure. A keloid may require a long-term control strategy rather than an aggressive attempt at complete removal. A scar whose visibility is already minor may not justify the recovery or pigment risk of further treatment.

The question is never simply whether something can be done.

It is whether changing this particular component of the scar is likely to produce enough improvement to justify another wound-healing event.

Frequently asked questions

Can a scar be removed completely?

I would not promise complete erasure. Scar tissue is structurally different from uninjured skin. Treatment can often make scars substantially less visible by improving contour, thickness, colour or texture.

What is the best treatment for acne scars?

There is no single best treatment because acne scars have different architectures. Tethered scars, broad shallow scars and narrow deep scars may require different mechanisms, and many patients have more than one subtype.

Does RF microneedling help acne scars?

It can be useful for selected atrophic acne scars and has a growing clinical evidence base. It is not necessarily sufficient for mechanically tethered or other scar types that require an additional targeted approach. :contentReference[oaicite:5]{index=5}

Can old scars still improve?

Yes. Mature scars can still respond to appropriately selected treatment. The strategy differs from early scar management because spontaneous maturation has largely occurred and the remaining structural features are clearer.

Should I wait a year before treating a surgical scar?

Not as an absolute rule. Many scar-revision decisions benefit from maturation, but early protective care and selected treatment can be appropriate when problematic thickening, symptoms or other abnormal behaviour begins. Timing depends on what the scar is doing.

Do silicone gels or sheets work?

Silicone-based scar care has evidence supporting its use particularly in prevention and management of hypertrophic scar formation. It does not erase an established structural scar but can be useful within the correct phase of care. :contentReference[oaicite:6]{index=6}

Can a keloid come back after treatment?

Yes. Recurrence is an important feature of keloid biology. Treatment is therefore often multimodal and aimed at long-term control rather than guaranteeing permanent cure.

Can surgery make a keloid worse?

Surgery alone can create another injury capable of stimulating keloid recurrence. Excision may still have a role in selected multimodal plans, but it should not be treated as simple removal of the disease tendency.

Is scar revision the same as scar removal?

No. Revision replaces or rearranges an existing scar by creating a new wound under more favourable conditions. The aim is a better scar, not scar-free skin.

Why does my scar look darker?

Post-inflammatory pigmentation may coexist with the structural scar. Pigment and scar contour should be assessed separately because improving one does not automatically correct the other.

When would you recommend leaving a scar alone?

If a scar is still maturing normally, already minimally visible, or the likely gain from another procedure is smaller than the recovery, recurrence or pigment risk, observation and conservative care can be the better option.